Table 1. Clinical and pathological features of US and UCS patients (n=40).
| Variables | Categories | US/UCS n (%) |
|---|---|---|
| Age | >50 years | 33 (82) |
| ≤50 years | 7 (18) | |
| N.A. | 0 (0) | |
| Postmenopausal Bleeding | Yes | 22 (55) |
| No | 13 (33) | |
| N.A. | 5 (12) | |
| Adjuvant Treatment | No | 8 (20) |
| RT | 19 (47) | |
| CT | 8 (20) | |
| RT+CT | 5 (13) | |
| N.A. | 0 (0) | |
| Metastasis or Recurrence | Yes | 22 (55) |
| No | 14 (35) | |
| N.A. | 4 (10) | |
| Status | Alive | 11 (27) |
| Death | 23 (58) | |
| Loss of follow-up | 6 (15) | |
| N.A. | 0 (0) |
radiotherapy (RT); chemotherapy (CT); not available (NA); uterine sarcomas (US).
*ULM samples were not included owing to their benign characterization.